(Q41353182)

17 June 2018

title

Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S. (English)

1 reference

17 June 2018

1 reference

S Fujioka

1

1 reference

17 June 2018

N Kohno

series ordinal

2

1 reference

17 June 2018

K Hiwada

series ordinal

3

1 reference

17 June 2018

publication date

1 April 1995

1 reference

17 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

17 June 2018

volume

86

1 reference

17 June 2018

issue

4

1 reference

17 June 2018

page(s)

368-373

1 reference

17 June 2018

Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Establishment and characterization of new cell line (YMB-1) derived from human breast carcinoma.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Inhibitory effect of bestatin on the growth of human leukemic cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Aminopeptidase activities on the surface of mammalian cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920833

Immunomodulatory and therapeutic properties of bestatin in mice

22 June 2018

1 reference

12 December 2020

Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody

1 reference

12 December 2020

Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial

1 reference

12 December 2020

Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma

1 reference

12 December 2020

Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults

1 reference

12 December 2020

Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice

1 reference

12 December 2020

Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation

1 reference

12 December 2020

Ubenimex in the treatment of acute nonlymphocytic leukemia in adults

1 reference

12 December 2020

Expression of E- and P-cadherin in gastric carcinomas

1 reference

12 December 2020

10.1111/J.1349-7006.1995.TB03066.X

Identifiers

DOI

1 reference

17 June 2018

PMC publication ID

5920833

1 reference

17 June 2018

PubMed publication ID

7775259

1 reference

17 June 2018